Wu YF, Cao MF, Gao YP, Chen F, Wang T, Zumbika EP, Qian KX. Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells. World J Gastroenterol 2004; 10(20): 2944-2948
Corresponding Author of This Article
Kai-Xian Qian, College of Life Sciences, Zhejiang University, Hangzhou 310027, Zhejiang Province,China. email@example.com
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells
Yi-Feng Wu, Ming-Fu Cao, Yan-Ping Gao, Fei Chen, Tao Wang, Edward P. Zumbika, Kai-Xian Qian
Yi-Feng Wu, Yan-Ping Gao, Kai-Xian Qian, College of Life Sciences, Zhejiang University, Hangzhou 310027, Zhejiang Province, China
Ming-Fu Cao, College of Life Sciences, Hangzhou Teachers college, Hangzhou 310012, Zhejiang Province, China
Fei Chen, Tao Wang, Edward P. Zumbika, School of Medicine, Zhejiang University, Hangzhou 310027, Zhejiang Province, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Supported by the National Key Technologies Research and Development Program of China during the 10th Five-Year Plan Period, No. 2002BA760C
Correspondence to: Kai-Xian Qian, College of Life Sciences, Zhejiang University, Hangzhou 310027, Zhejiang Province,China. firstname.lastname@example.org
Received: February 2, 2004 Revised: February 16, 2004 Accepted: February 21, 2004 Published online: October 15, 2004
AIM: To investigate the effect of schisandrin B (Sch B) on proliferation and apoptosis of human hepatoma SMMC-7721 cells in vitro and regulation of Hsp70 and Caspases-3, 7, 9 expression by Sch B.
METHODS: Human hepatoma cell line SMMC-7721 was cultured and treated with Sch B at various concentrations. Growth suppression was detected with MTT colorimetric assay. Cell apoptosis was confirmed by DNA ladder detection and flow cytometric analysis. The expression of Hsp70, Caspases-3, 7, 9 were analyzed by Western blot analysis.
RESULTS: Sch B inhibited the growth of hepatoma SMMC-7721 cells in a dose-dependent manner, leading to a 50% decrease in cell number (LC50) value of 23.50 mg/L. Treatment with Sch B resulted in degradation of chromosomal DNA into small internucleosomal fragments, evidenced by the formation of a 180-200 bp DNA ladder on agarose gels. FCM analysis showed the peak areas of subdiploid at the increased concentration of Sch B. The results of Western bolt analysis showed that Hsp70 was down-regulated and Caspase-3 was up-regulated, while the activity of Caspases-7, -9 had no significant change.
CONCLUSION: Sch B is able to inhibit the proliferation of human hepatoma SMMC-7721 cells and induce apoptosis, which goes through Caspase-3-dependent and Caspase-9-independent pathway accompanied with the down-regulation of Hsp70 protein expression at an early event.
Key Words: $[Keywords]
Citation: Wu YF, Cao MF, Gao YP, Chen F, Wang T, Zumbika EP, Qian KX. Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells. World J Gastroenterol 2004; 10(20): 2944-2948
Schisandrin B (Sch B, Figure 1) is a dibenzocyclooctadiene compound isolated from Fructus Schisandrae (FS, the fruit of Schisandra chinensis), an herb commonly prescribed in tonic and sedative formulae in Chinese medicine[1,2]. In clinical situations, FS was also found to produce beneficial effects on patients suffering from viral hepatitis. Recently, the pharmacological profile of FS, which includes the enhancement of liver functions and inhibitory/sedative effects on the central nervous system, has been established by laboratory investigations[4-9]. We presented evidence that Sch B was able to inhibit the proliferation of human hepatoma SMMC-7721 cells and induce apoptosis in vitro.
Figure 1 Chemical structure of Schisandrin B.
Apoptosis is an essential physiological process required for normal development and maintenance of tissue homeostasis[10,11]. Insufficient or excessive cell death can contribute to human diseases, including cancer, acquired immunodeficiency syndrome and some neurodegenerative disorders. Although many factors are involved in apoptotic program[13-16], Caspases, a family of cysteine proteases have been shown to play a major role in the transduction of apoptotic signals and the execution of apoptosis in mammalian[17-21], which has become recognized as key components of the apoptotic machinery. Most of the biochemical and morphological events of apoptosis are a direct result of Caspase-mediated cleavage of specific substrates[23,24] .
Inhibition of Caspases following treatment with apoptotic stimuli has been shown to prevent some features of apoptosis. The heat shock protein 70 (Hsp70) family of proteins has been demonstrated to be a potent inhibitor of apoptosis induced by a wide range of stimuli[25,26]. It can protect against apoptosis at an early event in the apoptotic pathway. A role for Hsp70 in tumorigenesis has been suggested, based on the observations that many transformed cells have elevated levels of Hsp70 and overexpression of Hsp70 in transgenic mice results in T-cell lymphoma[27-30].
In this study, Sch B induced human hepatoma SMMC-7721 cell apoptosis was confirmed by DNA ladder detection and flow cytometric analysis. At the same time, the modulation of Hsp70 and Caspases was observed to study the mechanism of Sch B induced apoptosis in human hepatoma SMMC-7721 cells.
MATERIALS AND METHODS
Sch B was purchased from National Institute for the Control of Pharmaceutical and Biological Products, China (NICPBP). The drug was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 g/L. For cell treatments, the samples were further diluted in culture medium with the final DMSO concentration < 5 g/L. Antibodies to Hsp70, Caspases-3, 7, 9 were purchased from Boster Biotech, China. RPMI-1640 culture medium was obtained from Gibco Co. USA. Fetal calf serum was supplied by Si-Ji-Qing Biotechnology Co. (Hangzhou, China). 96-well plates and culture bottles were purchased from Costar Co. USA. All other chemicals were purchased from Sigma Chemical (St. Louis, MO, USA).
Cell lines and culture
Human hepatoma cell line SMMC-7721 and human hepatic cell line HL-7702 were purchased from American Type Culture Collection (ATCC). Human endothelial cell line ECV-304 was obtained from Tumor Institute, Zhejiang University. Primary human fibroblast cell line was derived from fresh muscle tissues by enzymatic dissociation. Human lymphocytes were derived from umbilical blood by Ficoll-Hyaque separation method, and seeded in 96-well microplates with the concentration of phytoagglutinin (PHA). All the cell lines were grown as monolayers in RPMI1640 medium supplemented with 100 mL/L fetal calf serum and antibiotics (100 unit/mL penicillin and 100 μg/mL streptomycin), incubated at 37 °C in a humidified incubator containing 50 mL/L CO2 in air.
Assay of cell proliferation
SMMC-7721 cells (100 μL of cell suspension per well) were seeded at a density of 1.5 × 10 5/mL in 96-well plates. Each group had three wells with a non-treated group as control. When the cells anchored to the plates, various concentrations of Sch B were added and the slides were incubated at 37 °C in humidified atmosphere containing 50 mL/L CO2. When the cells described above were cultured for 48 h, 50 μL of MTT (2 mg/mL in PBS) was added to each well and cultured for another 4 h. After the supernatant was discarded, MTT formazan precipitates were dissolved in 100 μL of DMSO, shaken mechanically for 10 min and then read immediately at 570 nm in a plate reader. Cell proliferation inhibition rate (CPIR) was calculated using the following equation: CPIR = (1-average absorbance (A) value of experimental group/average A value of control group) × 100%.
Cell toxicity on primary cells or normal cell lines
HL-7702 cells, ECV-304 cells, primary human fibroblast cells, human lymphocytes (100 μL cell suspension per well) were seeded at a density of 1.0 × 10 5/mL in 96-well plates. Following treatment at the concentration of 10, 20, 40, 80, 160 mg/L Sch B for 24 h, cell viability was estimated by trypan blue exclusion. Six wells were measured for each concentration of test compound. All toxicity experiments were repeated at least three independent occasions.
DNA ladder demonstration
After exposed to Sch B for 12 h, SMMC-7721 cells (5 × 10 6/sample, both attached and detached cells) were collected and lysed with lysis buffer containing 50 mmoL Tris-HCl buffer (pH 7.5), 20 mmol/L EDTA, and 10 g/L NP-40. Then 10 g/L SDS and RNase (5 μg/mL) were added to the supernatant, and incubated at 56 °C for 2 h, followed by incubation with proteinase K (2.5 μg/mL) at 37 °C for 2 h. After the DNA was precipitated by addition of both ammonium acetate (3.3 mol/L) and ethanol (995 mL/L), it was dissolved in a gel loading buffer. DNA fragmentation was detected by electrophoresis on 15 g/L agarose gels and visualized with ethidium bromide staining.
Flow cytometric analysis
SMMC-7721 cells were seeded in culture flasks. When the cells were anchored to the plates, various concentrations (0, 10 μmol/L, 20 μmol/L, 40 μmol/L) of Sch B were added and the cells were incubated at 37 °C in humidified atmosphere containing 50 mL/L CO2 for 2 d. Then each group of cells were washed with PBS, trypsinized and fixed with 700 mL/L ethanol at -20 °C for 30 min, and they were stained with 1.0 μg/mL propidium iodide (PI, Boehringer Mannheim, Germany). The red fluorescence of DNA-bound PI in individual cells was measured at 488 nm with an Altra flow cytometer. The results were analyzed using the ExpoII software (Beckman Coulter, USA). Ten thousand events were analyzed for each sample.
Western blotting analysis
The cells were lysed in a lysis buffer (25 mmol/L hepes, 15 g/L Triton X-100, 10 g/L sodium deoxycholate, 1 g/L SDS, 0.5 mol/L NaCl, 5 mmol/L edetic acid, 50 mmol/L NaF, 0.1 mmol/L sodium vanadate, 1 mmol/L phenylmethylsulfonyl fluoride (PMSF) and 0.1 g/L leupeptin, pH7.8) at 4 °C with sonication. The lysates were centrifuged at 15 000 g for 15 min and the concentration of the protein in each lysate was determined with Coomassie brilliant blue G-250. Loading buffer (42 mmol/L Tris-HCl, containing 100 mL/L glycerol, 23 g/L SDS, 50 g/L 2-mercaptoethanol and 0.02 g/L bromophenol blue) was then added to each lysate, which was subsequently boiled for 3 min and then electrophoresed on a SDS-polyacrylamide gel. Proteins were transferred onto a nitrocellulose filter and incubated separately with antibodies against Hsp70, Caspases-3,7,9, then labeled with peroxidase-conjugated secondary antibodies. The reactions were visualized using the enhanced chemiluminescence reagent (Sigma). The results were approved by repeating the reactions twice.
All data were expressed as mean ± SD. Statistical analysis was performed by t test using software SPSS 11.0 for Windows. P < 0.05 was considered statistically significant.
Effect of Sch B on cell proliferation
Treatment of human hepatoma SMMC-7721 cells with Sch B resulted in a dose-dependent cytotoxicity. As shown in Figure 2, Sch B-mediated cytotoxicity occurred at a concentration greater than 20 mg/L for 48 h. A significant decrease in cell number was seen in the cells treated with Sch B at 20 mg/L. The concentration of Sch B leading to a 50% decrease in cell number (LC50) was about 23.5 mg/L.
Figure 2 Inhibition rate of Sch B on proliferation of SMMC-7721 cells.
Cells were incubated at concentrations of Sch B for 48 h.
Effect of Sch B on primary cells or normal cell line toxicity
As indicated in Figure 3, Sch B had little cytocidal effect on primary human fibroblast cells and human lymphocyte cells even if at the concentration of 160 mg/L. Treatment of human HL-7702, ECV-304 with Sch B resulted in a dose-dependent cytotoxicity. But human hepatic HL-7702 cells were more resistant to the Sch B-mediated cytotoxicity than human endothelial cells, ECV-304 cells and human hepatoma SMMC-7721.
Figure 3 Cytocidal effect of Sch B on growth of human endot-helial ECV-304 cells, human hepatic HL-7702 cells, primary human fibroblast cells and human lymphocyte cells.
Cells were incubated at concentrations (10, 20, 40, 80, 160 mg/L) of Sch B for 48 h.
Detection of DNA fragmentation in SMMC-7721 cells treated with Sch B
As shown in Figure 4, treatment with Sch B resulted in degradation of chromosomal DNA into small internucleosomal fragments, evidenced by the formation of a 180-200 bp DNA ladder on agarose gels, hallmark of cells undergoing apoptosis. No DNA ladders were detected in the samples isolated from control cultures. These results indicated that Sch B induced an apoptotic cell death in SMMC-7721 cells.
Figure 4 DNA fragmentation in SMMC-7721 cells treated with Sch B for 12 h.
M: size marker; C: control culture; lane 1: 20 mg/L Sch B treatment; lane 2: 40 mg/L Sch B treatment.
Flow cytometric analysis of cell apoptosis
SMMC-7721 cells were exposed to increased concentrations of Sch B (10 mg/L, 20 mg/L, 40 mg/L) for 48 h, and the growth of the cells was analyzed using flow cytometry (Figure 5). The peak value appearing before the G1 peak is called apoptotic peak. As shown in Figure 5 and Table 1, the apoptotic peak areas and rate increased with increased concentrations of Sch B.
Table 1 Apoptosis rate of SMMC-7721 cells induced by Sch B.
Figure 5 Cell apoptosis determined by flow cytometry.
SMMC-7721 cells were treated with Sch B at various concentrations (0, 10, 20, 40 mg/L, respectively A to D) for 48 h.
Effects of Sch B on expression of Hsp70 and Caspases-3,-7,-9
Recent reports suggested that Hsp70 might help to protect cells from apoptosis at an early event in the apoptotic pathway. To elucidate whether Hsp70 was modulated during Sch B induced apoptosis, we examined the expression of Hsp70 by Western blot. Moreover, it was shown that Caspases were the main factor in the apoptotic pathway. We investigated whether Caspases were involved in inducing SMMC-7721 cell apoptosis treated with Sch B. SMMC-7721 cells treated with Sch B for 48 h were analyzed for the enzymatic activity by Western blot. The results showed that Hsp70 was down-regulated and Caspase-3 was activated, while the activity of Caspases-7,-9 had no significant change (Figure 6).
Figure 6 Effect of Sch B on expression of Hsp70, Caspases-3, - 7, -9 proteins.
SMMC-7721 cells were treated with Sch B for 48 h. After treatment, cell lysates were extracted, and the level of Hsp70, Caspases-3, -7, -9 proteins were analyzed by Western bolt analysis. Beta-actin was used as an internal loading control. Lane 1: control; Lane 2: 20 mg/L Sch B treatment; lane 3: 40 mg/L Sch B treatment.
After human hepatoma SMMC-7721 cells were treated at various concentrations of Sch B for 48 h, MTT colorimetric analysis showed that Sch B could significantly inhibit the proliferation of SMMC-7721 cells, with LC50 value of 23.50 mg/L. While human hepatic HL-7702 cells were more resistant to the Sch B mediated cytotoxic activity than human endothelial ECV-304 cells and human hepatoma SMMC-7721 cells. It is interesting that Sch B had an unconspicuous cytocidal effect on primary human fibroblast cells and human lymphocyte cells.
Current antineoplastic therapies, including chemotherapy and radiation-therapy, are likely to be affected by the apoptotic tendency of cells. During apoptosis, certain characteristic morphologic events, such as nuclear condensation, nuclear fragmentation, and cell shrinkage, and biochemical events, such as DNA fragmentation, would occur[31-35]. In this study, we showed that Sch B induced human hepatoma SMMC-7721 cell apoptosis was confirmed by DNA ladder and cell cycle analyses.
The commitment of cell apoptosis requires the integration of numerous inputs involving multiple signal transduction pathways. Some cellular pathways and molecular regulators/ effectors of apoptosis have been identified. Many lines of evidence demonstrated that activation of Caspases is a central mechanism of apoptosis. So far, more than 15 members of Caspases have been reported in the literature, and most of them played a major role in apoptosis, participating in the initiation and execution of programmed cell death[36,37]. Based on their structure and function, Caspases are classified into two groups: initiator Caspases (such as Caspases-2,-8 and-9) and executor Caspases (such as Caspases-3, -6 and -7)[38,39]. In this study, Sch B-induced apoptosis of SMMC-7721 cells was accompanied with up-regulation of Caspase-3, but did not involve the regulation of Caspase-7 and Caspase-9 protein expression. These results suggested that Caspase-3 but not Caspase-7 was the “executors” of Sch B induced SMMC-7721 cell apoptosis that did not go through Caspase-9-dependent pathway.
Recent results indicated that Hsp70 might help to protect cells from apoptosis. Jaattela et al reported that Hsp70 exerted its anti-apoptotic function on downstream of Caspase-3. Creagh et al revealed that Hsp70 acted on upstream of the Caspases. In the presence of Hsp70, Caspase-3 was not processed or activated and the release of cytochrome C from the mitochondrial intermembrane space, a major Caspase activating mechanism, was inhibited. In this study, the down-modulation of Hsp70 was observed, indicating that Sch B could help Caspase-3 to release from the blockade of Hsp70 so as to promote human hepatoma SMMC-7721 cells to apoptosis.
In conclusion, Sch B is able to inhibit the proliferation of human hepatoma SMMC-7721 cells and induce apoptosis, which goes through Caspase-3-dependent and Caspase-9-independent pathways accompanied with the down-regulation of Hsp70 protein expression at an early event. Further investigation will focus on the identification of other signal modulations in this apoptosis pathway.
The authors are grateful to Professor Shu Zheng for her help in this study.
Edited by Kumar M and Wang XL Proofread by Xu FM
Liu JH, Ho SC, Lai TH, Liu TH, Chi PY, Wu RY. Protective effects of Chinese herbs on D-galactose-induced oxidative damage.Methods Find Exp Clin Pharmacol. 2003;25:447-452.
Hsieh MT, Tsai ML, Peng WH, Wu CR. Effects of Fructus schizandrae on cycloheximide-induced amnesia in rats.Phytother Res. 1999;13:256-257.
Li XY. Bioactivity of neolignans from fructus Schizandrae.Mem Inst Oswaldo Cruz. 1991;86 Suppl 2:31-37.
Chiu PY, Tang MH, Mak DH, Poon MK, Ko KM. Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins.Free Radic Biol Med. 2003;35:368-380.
Chiu PY, Mak DH, Poon MK, Ko KM. In vivo antioxidant action of a lignan-enriched extract of Schisandra fruit and an anthraquinone-containing extract of Polygonum root in comparison with schisandrin B and emodin.Planta Med. 2002;68:951-956.
Ko KM, Lam BY. Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain.Mol Cell Biochem. 2002;238:181-186.
Pan SY, Han YF, Carlier PR, Pang YP, Mak DH, Lam BY, Ko KM. Schisandrin B protects against tacrine- and bis(7)-tacrine-induced hepatotoxicity and enhances cognitive function in mice.Planta Med. 2002;68:217-220.
Ip SP, Yiu HY, Ko KM. Schisandrin B protects against menadione-induced hepatotoxicity by enhancing DT-diaphorase activity.Mol Cell Biochem. 2000;208:151-155.
Yim TK, Ko KM. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status.Mol Cell Biochem. 1999;196:151-156.
Souto PC, Brito VN, Gameiro J, da Cruz-Höfling MA, Verinaud L. Programmed cell death in thymus during experimental paracoccidioidomycosis.Med Microbiol Immunol. 2003;192:225-229.
Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway.Lancet Oncol. 2003;4:721-729.
Thompson CB. Apoptosis in the pathogenesis and treatment of disease.Science. 1995;267:1456-1462.
Wajant H, Pfizenmaier K, Scheurich P. TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy.Apoptosis. 2002;7:449-459.
Inoue H, Shiraki K, Yamanaka T, Ohmori S, Sakai T, Deguchi M, Okano H, Murata K, Sugimoto K, Nakano T. Functional expression of tumor necrosis factor-related apoptosis-inducing ligand in human colonic adenocarcinoma cells.Lab Invest. 2002;82:1111-1119.
Wei XC, Wang XJ, Chen K, Zhang L, Liang Y, Lin XL. Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NCI-N87.World J Gastroenterol. 2001;7:559-562.
MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.Oncogene. 2002;21:6809-6818.
Held J, Schulze-Osthoff K. Potential and caveats of TRAIL in cancer therapy.Drug Resist Updat. 2001;4:243-252.
Ruiz de Almodóvar C, Ruiz-Ruiz C, Muñoz-Pinedo C, Robledo G, López-Rivas A. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.Oncogene. 2001;20:7128-7133.
Ibrahim SM, Ringel J, Schmidt C, Ringel B, Müller P, Koczan D, Thiesen HJ, Löhr M. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.Pancreas. 2001;23:72-79.
Ohshima K, Sugihara M, Haraoka S, Suzumiya J, Kanda M, Kawasaki C, Shimazaki K, Kikuchi M. Possible immortalization of Hodgkin and Reed-Sternberg cells: telomerase expression, lengthening of telomere, and inhibition of apoptosis by NF-kappaB expression.Leuk Lymphoma. 2001;41:367-376.
Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.Cancer Res. 2003;63:230-235.
Thornberry NA, Lazebnik Y. Caspases: enemies within.Science. 1998;281:1312-1316.
Rhéaume E, Cohen LY, Uhlmann F, Lazure C, Alam A, Hurwitz J, Sékaly RP, Denis F. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis.EMBO J. 1997;16:6346-6354.
Song Q, Burrows SR, Smith G, Lees-Miller SP, Kumar S, Chan DW, Trapani JA, Alnemri E, Litwack G, Lu H. Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing.J Exp Med. 1996;184:619-626.
Samali A, Cotter TG. Heat shock proteins increase resistance to apoptosis.Exp Cell Res. 1996;223:163-170.
Lasunskaia EB, Fridlianskaia II, Darieva ZA, da Silva MS, Kanashiro MM, Margulis BA. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.Biotechnol Bioeng. 2003;81:496-504.
Liu TS, Musch MW, Sugi K, Walsh-Reitz MM, Ropeleski MJ, Hendrickson BA, Pothoulakis C, Lamont JT, Chang EB. Protective role of HSP72 against Clostridium difficile toxin A-induced intestinal epithelial cell dysfunction.Am J Physiol Cell Physiol. 2003;284:C1073-C1082.
Díez-Fernández C, Andrés D, Cascales M. Attenuating effects of heat shock against TGF-beta1-induced apoptosis in cultured rat hepatocytes.Free Radic Biol Med. 2002;33:835-846.
Neuhofer W, Lugmayr K, Fraek ML, Beck FX. Regulated overexpression of heat shock protein 72 protects Madin-Darby canine kidney cells from the detrimental effects of high urea concentrations.J Am Soc Nephrol. 2001;12:2565-2571.
Gibbons NB, Watson RW, Coffey RN, Brady HP, Fitzpatrick JM. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis.Prostate. 2000;45:58-65.
Mariggiò MA, Cafaggi S, Ottone M, Parodi B, Vannozzi MO, Mandys V, Viale M. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.Invest New Drugs. 2004;22:3-16.
Dong YG, Chen DD, He JG, Guan YY. Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells.Acta Pharmacol Sin. 2004;25:47-53.
Liu JB, Gao XG, Lian T, Zhao AZ, Li KZ. [Apoptosis of human hepatoma HepG2 cells induced by emodin in vitro].Ai Zheng. 2003;22:1280-1283.
Yoo HG, Jung SN, Hwang YS, Park JS, Kim MH, Jeong M, Ahn SJ, Ahn BW, Shin BA, Park RK. Involvement of NF-kappaB and caspases in silibinin-induced apoptosis of endothelial cells.Int J Mol Med. 2004;13:81-86.
Eriguchi M, Nonaka Y, Yanagie H, Yoshizaki I, Takeda Y, Sekiguchi M. A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines.Biomed Pharmacother. 2003;57:412-415.
Dalen H, Neuzil J. Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation.Br J Cancer. 2003;88:153-158.
Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, Pardee AB. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation.Cancer Res. 2003;63:290-295.
Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.J Biol Chem. 1994;269:30761-30764.
Törmänen-Näpänkangas U, Soini Y, Kahlos K, Kinnula V, Pääkkö P. Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma.Int J Cancer. 2001;93:192-198.
Jäättelä M, Wissing D, Kokholm K, Kallunki T, Egeblad M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases.EMBO J. 1998;17:6124-6134.
Creagh EM, Carmody RJ, Cotter TG. Heat shock protein 70 inhibits caspase-dependent and -independent apoptosis in Jurkat T cells.Exp Cell Res. 2000;257:58-66.